Nasal gels are topical medications applied inside the nostrils to alleviate symptoms like congestion, dryness, and allergies.

How big is the Nasal Gels Market?

The global Nasal Gels Market size was estimated at USD 8.8 Billion in 2023 and is expected to reach USD 15 Billion in 2033.

What is the Nasal Gels Market growth?

The global Nasal Gels Market is expected to grow at a compound annual growth rate of 5.52%. From 2024 To 2033

Who are the key companies/players in the Nasal Gels Market?

Some of the key players in the Nasal Gels Markets are Merck & Co., Inc., GlaxoSmithKline plc, Mystic Pharmaceuticals, Bausch Health Companies Inc. , B.F. Ascher & Company, Natesto, Medline, Lubrizol CDMO, Neurelis, Inc. , PendoPharm Inc.

What conditions do nasal gels treat?

Nasal gels treat nasal congestion, allergies, sinusitis, and dryness. They can also be used for central nervous system hormonal therapy and cardiovascular treatments.

Which region dominates the nasal gels market?

North America dominates the nasal gels market, holding 34% of the market share in 2023.

What is the leading distribution channel for nasal gels?

Retail pharmacies are the leading distribution channel, accounting for 35% of the market share.

What types of nasal gels are available?

Types of nasal gels include decongestants, saline nasal gels, antihistamines, and corticosteroids.

Global Nasal Gels Market By Type (Decongestants, Saline Nasal gel, Antihistamines, Corticosteroids, Other Types) By Application (Nasal Congestion, Central Nervous System Hormonal Therapy, Cardiovascular, Other Applications) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: June 2024
Report ID: 84536
Number of Pages: 219
Format:

- Merck & Co., Inc.
- GlaxoSmithKline plc
- Mystic Pharmaceuticals
- Bausch Health Companies Inc.
- B.F. Ascher & Company
- Natesto
- Medline
- Lubrizol CDMO
- Neurelis, Inc.
- PendoPharm Inc.
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 84536
Published Date June 2024
Rating
- ★★★★★
  
  ★★★★★
- (82)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)